DK404588A - Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents
Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelseInfo
- Publication number
- DK404588A DK404588A DK404588A DK404588A DK404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A DK 404588 A DK404588 A DK 404588A
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydrocabazole
- compound
- pharmaceutical preparation
- preparation containing
- alkanic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/076,424 US4808608A (en) | 1986-01-23 | 1987-07-21 | Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use |
Publications (2)
Publication Number | Publication Date |
---|---|
DK404588D0 DK404588D0 (da) | 1988-07-20 |
DK404588A true DK404588A (da) | 1989-03-16 |
Family
ID=22131920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK404588A DK404588A (da) | 1987-07-21 | 1988-07-20 | Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US4808608A (da) |
EP (1) | EP0300676A3 (da) |
JP (1) | JPS6470462A (da) |
KR (1) | KR890001987A (da) |
AU (1) | AU611454B2 (da) |
DK (1) | DK404588A (da) |
IL (1) | IL87079A0 (da) |
NZ (1) | NZ225361A (da) |
PT (1) | PT88044B (da) |
ZA (1) | ZA885209B (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940719A (en) * | 1986-03-27 | 1990-07-10 | Merck Frosst Canada, Inc. | Tetrahydrocarbazole esters, pharmaceutical compositions and use |
GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
US6300361B1 (en) | 1990-07-25 | 2001-10-09 | Novartis Ag | Stabilized pharmaceutical compositions comprising acid donors |
US5187180A (en) * | 1990-07-26 | 1993-02-16 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
US5221678A (en) * | 1990-07-26 | 1993-06-22 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
GB9101375D0 (en) * | 1991-01-22 | 1991-03-06 | Erba Carlo Spa | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole |
US5230350A (en) * | 1991-05-29 | 1993-07-27 | Tabex Industries, Inc. | Moisture barrier for indwelling catheters and the like |
DE4435477A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
US5830911A (en) * | 1996-08-14 | 1998-11-03 | American Home Products Corporation | Pyranoindole and tetrahydrocarbazole inhibitors of COX-2 |
US20010047027A1 (en) * | 2000-04-12 | 2001-11-29 | Marc Labelle | Prostaglandin D2 receptor antagonists |
US6410583B1 (en) | 2000-07-25 | 2002-06-25 | Merck Frosst Canada & Co. | Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
US7273883B2 (en) * | 2000-09-14 | 2007-09-25 | Allergan, Inc. | Prostaglandin EP4 antagonist |
US7217725B2 (en) * | 2000-09-14 | 2007-05-15 | Allergan, Inc. | Prostaglandin D2 antagonist |
AR038136A1 (es) | 2002-01-24 | 2004-12-29 | Merck Frosst Canada Inc | Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento |
CA2503767C (en) | 2002-10-30 | 2009-09-22 | Merck Frosst Canada & Co./Merck Frosst Canada & Cie | Pyridopyrrolizine and pyridoindolizine derivatives |
WO2004063156A1 (en) * | 2003-01-08 | 2004-07-29 | Biovitrum Ab | Novel indole derivates as fabp-4 inhibitors |
AR041089A1 (es) * | 2003-05-15 | 2005-05-04 | Merck & Co Inc | Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas |
CA2526013A1 (en) * | 2003-05-20 | 2004-12-02 | Merck Frosst Canada Ltd. | Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists |
EP1638967A2 (en) * | 2003-06-12 | 2006-03-29 | Merck Frosst Canada Ltd. | Cycloalkanepyrrolopyridines as dp receptor antagonists |
ATE464048T1 (de) * | 2003-08-07 | 2010-04-15 | Merck Sharp & Dohme | Behandlung von alzheimer-krankheit und verwandten zuständen |
US7019022B2 (en) * | 2003-12-15 | 2006-03-28 | Merck Frosst Canada & Co. | Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
CN1930162B (zh) * | 2004-03-11 | 2010-06-16 | 埃科特莱茵药品有限公司 | 四氢吡啶并吲哚衍生物 |
CA2594280C (en) | 2004-12-27 | 2013-04-23 | Anja Fecher | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
US8076315B2 (en) | 2005-10-14 | 2011-12-13 | The Board Of Trustees Of The University Of Illinois | Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists |
SI2051962T1 (sl) * | 2006-08-07 | 2012-02-29 | Actelion Pharmaceuticals Ltd | Derivati (3-amino-1,2,3,4-tetrahidro-9h-karbazol-9-il)-ocetne kisline |
WO2008097535A2 (en) * | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Method of treating atherosclerosis, dyslipidemias and related conditions |
WO2008099907A1 (ja) | 2007-02-16 | 2008-08-21 | Ono Pharmaceutical Co., Ltd. | 尿排出障害治療剤 |
KR101444572B1 (ko) | 2010-03-22 | 2014-09-24 | 액테리온 파마슈티칼 리미티드 | 3-(헤테로아릴-아미노)-1,2,3,4-테트라히드로-9h-카르바졸 유도체 및 이의 프로스타글란딘 d2 수용체 조절제로서의 용도 |
ES2596581T3 (es) | 2011-04-14 | 2017-01-10 | Actelion Pharmaceuticals Ltd. | Derivados de ácido 7-(heteroaril-amino)-6,7,8,9-tetrahidropirido[1,2-a]indol acético y su uso como moduladores del receptor de prostaglandina D2 |
MY179356A (en) | 2014-03-17 | 2020-11-05 | Idorsia Pharmaceuticals Ltd | Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
CA2938107A1 (en) | 2014-03-18 | 2015-09-24 | Actelion Pharmaceuticals Ltd | Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
TWI711616B (zh) | 2015-09-15 | 2020-12-01 | 瑞士商愛杜西亞製藥有限公司 | 結晶型式 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
US4009181A (en) * | 1973-01-22 | 1977-02-22 | Hoffmann-La Roche Inc. | Cyclopenta[b]indole-2-carboxylic acids and derivatives thereof |
US4057559A (en) * | 1973-10-01 | 1977-11-08 | American Home Products Corporation | Carbazole acetic acid derivatives |
ATE61047T1 (de) * | 1986-01-23 | 1991-03-15 | Merck Frosst Canada Inc | Tetrahydrocarbazol-1-alkansaeuren. |
-
1987
- 1987-07-21 US US07/076,424 patent/US4808608A/en not_active Expired - Fee Related
-
1988
- 1988-07-11 NZ NZ225361A patent/NZ225361A/xx unknown
- 1988-07-12 IL IL87079A patent/IL87079A0/xx unknown
- 1988-07-13 EP EP88306392A patent/EP0300676A3/en not_active Ceased
- 1988-07-19 ZA ZA885209A patent/ZA885209B/xx unknown
- 1988-07-20 AU AU19262/88A patent/AU611454B2/en not_active Expired - Fee Related
- 1988-07-20 DK DK404588A patent/DK404588A/da not_active Application Discontinuation
- 1988-07-20 PT PT88044A patent/PT88044B/pt not_active IP Right Cessation
- 1988-07-20 KR KR1019880009051A patent/KR890001987A/ko not_active Application Discontinuation
- 1988-07-21 JP JP63180475A patent/JPS6470462A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ225361A (en) | 1991-06-25 |
PT88044B (pt) | 1995-03-01 |
DK404588D0 (da) | 1988-07-20 |
IL87079A0 (en) | 1988-12-30 |
PT88044A (pt) | 1989-06-30 |
EP0300676A3 (en) | 1991-07-03 |
EP0300676A2 (en) | 1989-01-25 |
ZA885209B (en) | 1989-03-29 |
JPS6470462A (en) | 1989-03-15 |
AU611454B2 (en) | 1991-06-13 |
US4808608A (en) | 1989-02-28 |
KR890001987A (ko) | 1989-04-07 |
AU1926288A (en) | 1989-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK404588A (da) | Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK314789A (da) | Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK284485A (da) | Indol-2-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK655288A (da) | Diarylstyrylquinolindisyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK406389A (da) | Thiazolo(4,5,d)pyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK85985A (da) | Carbamoyl- eller acyl-4-aza-5alfa-androst-1-en-3-on og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK287085D0 (da) | Triazolobenzodiazepin og farmaceutisk praeparat indeholdende en saadanforbindelse | |
DK224589D0 (da) | Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK287188A (da) | Cephalosporinforbindelser og farmaceutisk praeparat deraf | |
DK48886A (da) | Akryl- eller heteroarylforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK537288A (da) | Tetrahydrocarbazolester og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK375584D0 (da) | Piperidinoquinazolinforbindelser og farmaceutisk praeparat indeholdene en saadan forbindelse | |
DK48790A (da) | Steroidforbindelse og farmaceutisk praeparat indeholden en saadan forbindelse | |
DK314386A (da) | Quinoloncarboxyylsyreforbindelse og antibakterielle farmaceutiske praeparater indeholdende denne | |
DK23088A (da) | Piperazinylpyrimidinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK191787D0 (da) | Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK680787A (da) | Farmaceutisk praeparat indeholdende en pyranoquinolinforbindelse | |
DK258086A (da) | Substitueret hexahydroarylquinolin og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK404488A (da) | Cyclohept(b)indolalkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK60187A (da) | Bis-diozopiperazin-derivater og laegemiddelformuleringer indeholdende saadanne forbindelser | |
DK669287D0 (da) | Farmaceutisk praerarat indeholdende en pyranoquinolinforbindelse | |
DK330389D0 (da) | Tetrahydropyranonforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK513588A (da) | Thieno(2,3-b)furan-2-sulfonamid og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK155006C (da) | Kondenserede imidazolderivater og farmaceutisk praeparat indeholdende en saadan forbindelse | |
DK53191D0 (da) | Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |